You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitor (ICI) therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)

Not yet recruiting
  • Unspecified Adult Solid Tumor, Protocol Specific
  • (no location specified)
Jun 23, 2022

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Immune Checkpoint Inhibitors
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023

Genito-Urinary Tumor Trial in Duarte (Biospecimen Collection(Punch Biopsy))

Active, not recruiting
  • Genito-Urinary Neoplasm
  • Biospecimen Collection(Punch Biopsy)
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

NSCLC, Immune Checkpoint Inhibitors Trial in Seoul (F-18 FDG PET/CT)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Immune Checkpoint Inhibitors
  • F-18 FDG PET/CT
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2022

Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

Recruiting
  • Breast Cancer
  • +12 more
  • Checkpoint Blockade, Immune
  • Brussel, Anderlecht, Belgium
    Institut Jules Bordet
Jul 1, 2022

Bladder Cancer Trial in Dallas (personalized ultrafractionated stereotactic ablative radiotherapy)

Recruiting
  • Bladder Cancer
  • personalized ultrafractionated stereotactic ablative radiotherapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 24, 2022

Healthcare Resource Utilization and Costs of Immune Checkpoint

Completed
  • Melanoma
    • East Hanover, New Jersey
      Novartis
    May 12, 2023

    Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Trial (NRC-2694-A, Paclitaxel)

    Recruiting
    • Carcinoma
    • Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    • Los Angeles, California
    • +2 more
    Nov 23, 2022

    NSCLC Associated With Leptomeningeal Metastases Trial (Tislelizumab, pemetrexed)

    Not yet recruiting
    • NSCLC Associated With Leptomeningeal Metastases
    • Tislelizumab, pemetrexed
    • (no location specified)
    Nov 21, 2023

    CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

    Recruiting
    • Myocarditis
    • +5 more
    • Paris, France
      AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
    Aug 19, 2022

    Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

    Not yet recruiting
    • Colitis
    • Aalborg, Denmark
    • +2 more
    Jul 7, 2023

    Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)

    Recruiting
    • Immune Related Adverse Events
    • +3 more
    • Freiburg, Baden-Württemberg, Germany
      Medical Center - University of Freiburg Albert-Ludwigs-Universit
    Jun 9, 2022

    Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

    Enrolling by invitation
    • Malignant Ascites
    • Taichung, Please Select, Taiwan
      China Medical University Hospital
    Feb 16, 2023

    Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)

    Recruiting
    • Non Small Cell Lung Cancer Metastatic
    • Advanced Melanoma
    • FMT + ICI
    • Toronto, Ontario, Canada
    • +3 more
    Aug 19, 2022

    Quality of Life and Physical Fitness After Immune Checkpoint

    Completed
    • Melanoma
    • Non Small Cell Lung Cancer
      • Groningen, Netherlands
        University Medical Center Groningen
      Jan 3, 2023

      Troponin to Detect Major Cardiovasculaire Advserse Events on

      Recruiting
      • Cancer
      • +2 more
      • No intervention
      • Paris, France
        Institut Mutualiste Montsouris
      Aug 22, 2023

      The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in

      Recruiting
      • Non-Small-Cell Lung Carcinoma
      • +3 more
      • Checkpoint Inhibitor, Immune
      • Elizabethtown, Kentucky
        Baptist Health Clinical Research
      Apr 25, 2022

      Non Small Cell Lung Cancer Trial in United States (Aglatimagene besadenovec)

      Recruiting
      • Non Small Cell Lung Cancer
      • Aglatimagene besadenovec
      • Farmington, Connecticut
      • +10 more
      Mar 28, 2022

      NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +4 more
      • Stereotactic body radiotherapy
      • +2 more
      • (no location specified)
      Jul 5, 2022

      Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

      Recruiting
      • Lung Squamous Cell Carcinoma
      • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
      • Yancheng, Jiangsu, China
        Yancheng Clinical College of Xuzhou Medical University
      Mar 21, 2023

      Melanoma, NSCLC Trial (Evaluation of ctDNA using the F1T after 1 year of immunotherapy)

      Not yet recruiting
      • Melanoma
      • Non-small Cell Lung Cancer
      • Evaluation of ctDNA using the F1T after 1 year of immunotherapy
      • (no location specified)
      Nov 24, 2023

      Development ofEORTC Immune Checkpoint Inhibitor-specific Quality

      Recruiting
      • Cancer
      • +2 more
        • Paris, France
          Institut Curie
        Nov 2, 2022

        Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

        Recruiting
        • Advanced Biliary Tract Cancer
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Mar 22, 2023

        Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer

        Completed
        • Cancer Treated With Immune-checkpoint Inhibitors
        • Immune checkpoint inhibitor
        • Bordeaux, France
          Institut Bergonié, Comprehensive Cancer Center
        Dec 6, 2021